Status:
COMPLETED
Hypermetabolism in ALS Using Six REE Formulas
Lead Sponsor:
University Hospital, Limoges
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Introduction: About 50-60% of Amyotrophic Lateral Sclerosis (ALS) is characterized by hypermetabolism, defined as 10% or more excess resting energy expenditure (REE) compared to theoretical values. Ha...
Eligibility Criteria
Inclusion
- ALS patients
- 18 years old or more
- IC and nutritional assessment within 1.5 months
- delay between diagnosis and IC \< 12 months
Exclusion
- \-
Key Trial Info
Start Date :
November 1 1996
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
449 Patients enrolled
Trial Details
Trial ID
NCT03382392
Start Date
November 1 1996
End Date
November 1 2014
Last Update
December 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Limoges, France, 87 042